Roche, DeCode Genetics Expand Alliance To Focus On DNA-Based Diagnostics
This article was originally published in The Gray Sheet
Executive Summary
Roche Diagnostics' five-year agreement with DeCode Genetics to develop DNA-based diagnostic products builds on the firms' 1998 gene discovery alliance targeting 12 disease states, including adult onset diabetes and schizophrenia.